Novo Nordisk receives FDA approval for Norditropin® FlexPro® for growth hormone treatment
- Details
- Category: Novo Nordisk

FDA Advisory Committee Recommends Approval of Belatacept
- Details
- Category: Bristol-Myers Squibb

Initiation of Phase 2 Clinical Trial Investigating Three Individual HCV Antivirals
- Details
- Category: Abbott

Nycomed on track in 2009 with strong growth in Key Products
- Details
- Category: Nycomed

GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
- Details
- Category: GlaxoSmithKline

Phase III study of Avastin in advanced stomach cancer did not meet primary endpoint
- Details
- Category: Roche

Pfizer's Prevnar 13 Recommended by CDC's Advisory Committee On Immunization Practices
- Details
- Category: Pfizer

More Pharma News ...
- FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
- Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
- Novartis receives FDA approval of Menveo®
- US FDA approves Rituxan/MabThera for the most common type of adult leukemia
- GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia
- GSK rejects conclusions reported in The New York Times story on Avandia
- GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizantâ¢